Shubhmita Bhatnagar

About Shubhmita Bhatnagar

Shubhmita Bhatnagar, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at University of Minnesota-Twin Cities, specializes in the field of Formulation development, Cancer immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Protein-Based Microneedles for Drug and Vaccine Delivery

EGFR-targeted mesenchymal stem cells for enhanced tumor retention and inhibition

Sulfobutylether-β-cyclodextrin hydrogel microspheres delivering TLR 7/8 agonist for transarterial immunoembolization

Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing

Enhancing anticancer efficacy of chemotherapeutics using targeting ligand-functionalized synthetic antigen receptor-mesenchymal stem cells

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy

CD133-targeting silicate prodrug nanoparticles for effective cancer stem cell targeting

STING and TLR 7/8 Agonist combination can improve immune checkpoint blockade therapy efficiency

Shubhmita Bhatnagar Information

University

Position

___

Citations(all)

991

Citations(since 2020)

885

Cited By

372

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

14

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Shubhmita Bhatnagar Skills & Research Interests

Formulation development

Cancer immunotherapy

Top articles of Shubhmita Bhatnagar

Protein-Based Microneedles for Drug and Vaccine Delivery

2024

EGFR-targeted mesenchymal stem cells for enhanced tumor retention and inhibition

Cancer Research

2023/4/4

Shubhmita Bhatnagar
Shubhmita Bhatnagar

H-Index: 10

Xiaolei Li
Xiaolei Li

H-Index: 5

Swayam Prabha
Swayam Prabha

H-Index: 17

Sulfobutylether-β-cyclodextrin hydrogel microspheres delivering TLR 7/8 agonist for transarterial immunoembolization

Cancer Research

2023/4/4

Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing

Materials Today Bio

2023/4/1

Enhancing anticancer efficacy of chemotherapeutics using targeting ligand-functionalized synthetic antigen receptor-mesenchymal stem cells

Pharmaceutics

2023/6/15

Xiaolei Li
Xiaolei Li

H-Index: 5

Shubhmita Bhatnagar
Shubhmita Bhatnagar

H-Index: 10

Swayam Prabha
Swayam Prabha

H-Index: 17

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy

Cancers

2022/12/11

CD133-targeting silicate prodrug nanoparticles for effective cancer stem cell targeting

Cancer Research

2022/6/15

STING and TLR 7/8 Agonist combination can improve immune checkpoint blockade therapy efficiency

Cancer Research

2022/6/15

Cancer stem cells and strategies for targeted drug delivery

2021/10

Synthetic receptor-based targeting strategies to improve tumor drug delivery

2021/4

Shubhmita Bhatnagar
Shubhmita Bhatnagar

H-Index: 10

Swayam Prabha
Swayam Prabha

H-Index: 17

Advanced materials for drug delivery across mucosal barriers

2021/1/1

Shubhmita Bhatnagar
Shubhmita Bhatnagar

H-Index: 10

Venkata Vamsi Krishna Venuganti
Venkata Vamsi Krishna Venuganti

H-Index: 18

See List of Professors in Shubhmita Bhatnagar University(University of Minnesota-Twin Cities)

Co-Authors

academic-engine